Antidepressant prescription rates and suicide attempt rates from 2004 to 2016 in a nationally representative sample of adolescents in the USA

Affiliations

¹ Department for Crisis Intervention and Suicide Prevention and Department for Clinical Psychology, University Clinic for Psychiatry, Psychotherapy, and Psychosomatics, Paracelsus Medical University, Salzburg, Austria.
² Department of Applied Psychology, Zurich University of Applied Sciences, Zurich, Switzerland.

M Plöderl et al. Epidemiol Psychiatr Sci. 2019 Oct.

. 2019 Oct;28(5):589-591.

doi: 10.1017/S2045796018000136. Epub 2018 Apr 10.

¹ Department for Crisis Intervention and Suicide Prevention and Department for Clinical Psychology, University Clinic for Psychiatry, Psychotherapy, and Psychosomatics, Paracelsus Medical University, Salzburg, Austria.
² Department of Applied Psychology, Zurich University of Applied Sciences, Zurich, Switzerland.

No abstract available

Figures

1. Barbui C, Esposito E, Cipriani A (2009). Selective serotonin reuptake inhibitors and risk of suicide: a systematic review of observational studies. Canadian Medical Association Journal 180, 291–297. - PMC - PubMed
1. Bjorkenstam C, Moller J, Ringback G, Salmi P, Hallqvist J, Ljung R (2013). An association between initiation of selective serotonin reuptake inhibitors and suicide – a nationwide register-based case-crossover study. PLoS ONE 8, e73973. - PMC - PubMed
1. Courtet P, Lopez-Castroman J, Jaussent I, Gorwood PA (2014). Antidepressant dosage and suicidal ideation. JAMA Internal Medicine 174, 1863–1865. - PubMed
1. Gibbons RD, Brown CH, Hur K, Marcus SM, Bhaumik DK, Erkens JA, Herings RM, Mann JJ (2007). Early evidence on the effects of regulators’ suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry 164, 1356–1363. - PubMed
1. Hammad TA, Laughren T, Racoosin J (2006). Suicidality in pediatric patients treated with antidepressant drugs. Archives of General Psychiatry 63, 332–339. - PubMed